99 related articles for article (PubMed ID: 25982745)
1. Hepatocyte fate upon TGF-β challenge is determined by the matrix environment.
Meyer C; Liebe R; Breitkopf-Heinlein K; Liu Y; Müller A; Rakoczy P; Thomas M; Weng H; Bachmann A; Ebert M; Dooley S
Differentiation; 2015 Jun; 89(5):105-16. PubMed ID: 25982745
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.
Godoy P; Hengstler JG; Ilkavets I; Meyer C; Bachmann A; Müller A; Tuschl G; Mueller SO; Dooley S
Hepatology; 2009 Jun; 49(6):2031-43. PubMed ID: 19274752
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
5. Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes.
Franco DL; Mainez J; Vega S; Sancho P; Murillo MM; de Frutos CA; Del Castillo G; López-Blau C; Fabregat I; Nieto MA
J Cell Sci; 2010 Oct; 123(Pt 20):3467-77. PubMed ID: 20930141
[TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.
Caja L; Bertran E; Campbell J; Fausto N; Fabregat I
J Cell Physiol; 2011 May; 226(5):1214-23. PubMed ID: 20945437
[TBL] [Abstract][Full Text] [Related]
7. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.
Valdés F; Alvarez AM; Locascio A; Vega S; Herrera B; Fernández M; Benito M; Nieto MA; Fabregat I
Mol Cancer Res; 2002 Nov; 1(1):68-78. PubMed ID: 12496370
[TBL] [Abstract][Full Text] [Related]
8. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
9. Reversible manipulation of apoptosis sensitivity in cultured hepatocytes by matrix-mediated manipulation of signaling activities.
Godoy P; Schug M; Bauer A; Hengstler JG
Methods Mol Biol; 2010; 640():139-55. PubMed ID: 20645050
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis.
Meindl-Beinker NM; Dooley S
J Gastroenterol Hepatol; 2008 Mar; 23 Suppl 1():S122-7. PubMed ID: 18336655
[TBL] [Abstract][Full Text] [Related]
11. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
[TBL] [Abstract][Full Text] [Related]
12. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.
Del Castillo G; Murillo MM; Alvarez-Barrientos A; Bertran E; Fernández M; Sánchez A; Fabregat I
Exp Cell Res; 2006 Sep; 312(15):2860-71. PubMed ID: 16828470
[TBL] [Abstract][Full Text] [Related]
13. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
Brockhausen J; Tay SS; Grzelak CA; Bertolino P; Bowen DG; d'Avigdor WM; Teoh N; Pok S; Shackel N; Gamble JR; Vadas M; McCaughan GW
Liver Int; 2015 Jan; 35(1):240-53. PubMed ID: 24576072
[TBL] [Abstract][Full Text] [Related]
14. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta1 regulation in hepatocyte-NIH3T3 co-culture is important for the enhanced hepatocyte function in 3D microenvironment.
Chia SM; Lin PC; Yu H
Biotechnol Bioeng; 2005 Mar; 89(5):565-73. PubMed ID: 15669090
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 induced epithelial-mesenchymal transition in hepatic fibrosis.
Bi WR; Yang CQ; Shi Q
Hepatogastroenterology; 2012 Sep; 59(118):1960-3. PubMed ID: 22369740
[TBL] [Abstract][Full Text] [Related]
17. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kim KK; Kugler MC; Wolters PJ; Robillard L; Galvez MG; Brumwell AN; Sheppard D; Chapman HA
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13180-5. PubMed ID: 16924102
[TBL] [Abstract][Full Text] [Related]
18. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
[TBL] [Abstract][Full Text] [Related]
19. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma.
Giannelli G; Bergamini C; Fransvea E; Sgarra C; Antonaci S
Gastroenterology; 2005 Nov; 129(5):1375-83. PubMed ID: 16285938
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
